Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06229106 · ClinicalTrials.gov registry record · Phase 4
Symfony vs Vivity in Dim Light
A Phase 4 study of Cataract, sponsored by Carolina Eyecare Physicians.
- Completed
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
- 2
- Study locations
NCT06229106 is a Phase 4 study of Cataract that has completed, run by Carolina Eyecare Physicians. The registered enrollment target is 64 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06229106, a Phase 4 study of Cataract, has completed, sponsored by Carolina Eyecare Physicians.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the visual outcomes of the Symfony lens and the Vivity lens under mesopic lighting conditions in adult patients undergoing routine cataract surgery. Participants will be asked to read a visual acuity chart at different distances in dim light.
Conditions Studied
Interventions
- DEVICE Vivity IOL
- DEVICE Symfony IOL
Study Locations (2)
Florida
- Center for Sight - Sarasota
South Carolina
- Carolina Eyecare Physicians, LLC - Mt. Pleasant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2024-10-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06229106
The ClinicalTrials.gov registry entry for NCT06229106 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (72% lower). The listed sponsor is Carolina Eyecare Physicians, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which Vivity IOL is the first listed.
NCT06229106 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, South Carolina.
Frequently Asked Questions
What is clinical trial NCT06229106 about?
NCT06229106 is a clinical study titled "Symfony vs Vivity in Dim Light". The purpose of this study is to evaluate the visual outcomes of the Symfony lens and the Vivity lens under mesopic lighting conditions in adult patients undergoing routine cataract surgery. Participants will be asked to read a visual acuity chart at different distances in dim light.
What is the current status of trial NCT06229106?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2023-12-01. Estimated completion is 2024-10-30.
What conditions does trial NCT06229106 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT06229106?
The interventions under investigation include: Vivity IOL (DEVICE), Symfony IOL (DEVICE).
Who is sponsoring clinical trial NCT06229106?
This trial is sponsored by Carolina Eyecare Physicians, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06229106 being conducted?
This trial has 2 study locations across Florida, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.